XXOL's pitch is not the ingredient. Everyone already has PDRN — its pitch is the delivery

Ask for PDRN this year and you will not be short of Korean brands to say yes. It is already in 49 of the 535 products in our catalogue — more than any other named active — which means a new two-SKU brand cannot win an order on the ingredient alone. Everyone in the room is holding the same card.

XXOL's answer is to stop arguing about the card and argue about how it is played. The brand's stated question is not how much PDRN, but how effectively the skin can use it — a delivery argument rather than a concentration argument.

The brand

XXOL is young — the brand entered our catalogue this year — and deliberately narrow: two products, sold as one system rather than two separate SKUs. The brand calls it Skin Architecture: Fill-Up Serum "fills," Radiance Cream "seals," and the two are marketed to be bought and used together rather than picked apart.

That is a different commercial object from most single-hero launches. You are not being offered an ingredient story to slot next to a competitor's; you are being offered a two-step ritual with a before/after role for each product, which is easier to merchandise as a set and harder to substitute one-for-one against a shelf that already has PDRN elsewhere.

Delivery over dosage

The formula pairs PDRN with a stated Marine Complex and what the brand describes as an absorption-focused approach, rather than leading with a percentage claim. That framing is worth taking at face value rather than at its word: a percentage number is checkable against a certificate of analysis, an "absorption-focused" claim is not, and buyers who need the former for a regulator or a retail partner should ask XXOL for it directly before it goes in their own listing copy.

What is checkable from the ingredient list itself: Niacinamide sits high in both formulas, which supports the brand's separate dual brightening and wrinkle-care claim independent of how the PDRN delivery story is judged. That gives a buyer two argument to fall back on if a market's advertising rules are cautious about unproven delivery-mechanism language — brighten-and-firm is a well-understood, easier claim to clear than "delivers more efficiently."

Why the pairing matters more than either SKU

A serum sold alone competes with every other PDRN serum on the shelf. A serum sold as step one of two, with a cream engineered as its explicit partner, competes with routines instead — and a routine sells a second SKU on the strength of the first, which is the same commercial logic that makes multi-step Korean skincare work as an export category in the first place.

It is also, practically, the easier line to sample: both SKUs are in the Naru Box programme, so a buyer can test the two-step claim as XXOL intends it to be used rather than judging the serum in isolation.

Compliance

No certification documents are on file with us yet for either SKU, which is ordinary for a brand this new — ask us and we will request them before you commit to an order. The full INCI is published for both products, which is the more immediate document most import desks will ask for first.

Who this fits

Carry it if you want a PDRN entry that is not competing purely on the ingredient — a buyer who already stocks two or three PDRN serums and wants a set-sell story rather than a fourth alternative. The two-step structure also suits a retailer that likes to build routine bundles rather than sell single heroes.

Skip it if your market's advertising standards are strict about mechanism claims ("delivery," "absorption") without a lab report behind them — ask for substantiation before that language goes in your own copy, and be ready to fall back on the brightening/wrinkle-care claim if it does not arrive in time. Skip it too if you specifically need a track record: XXOL has no certification history with us yet, and a buyer who needs that paper trail today will need to wait for it.